Effect of thyroid hormone status on Monocyte‐to‐high‐density lipoprotein ratio and the other systemic inflammation markers in patients with moderate‐to‐severe Thyroid Eye Disease
Author: Atike Burçin Tefon Arıbaş
Base Hospital / Institution: Bilkent City Hospital
ePoster presentation
Abstract ID: 25-350
Purpose
The aim of this study was to evaluate the systemic inflammation in inactive moderate to severe Thyroid eye disease (TED) patients with abnormal thyroid function by using the change in monocyte‐to‐high‐density lipoprotein ratio (MHR) and the other systemic inflammatory markers and to compare these findings in moderate to severe TED patients with regulated thyroid function and healthy controls.
Methods
In this retrospective study, 25 healthy individuals composed Group 1, 55 TED patients with normal thyroid function for at least 3 months composed Group 2, and 33 TED patients with abnormal thyroid function composed Group 3. Demographic data, lipid profile including HDLc, complete blood cell (CBC) data, and systemic inflammatory markers including MHR, systemic immune-inflammatory index (SII), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) were compared between the groups.
Results
There was no statistically significant difference between groups in terms of age, sex, and smoking habits (p>0.05). There was a statistically significant difference in HDL (p=0.001), and MHR (p=0.006) values in Group 3 compared to healthy controls. Moreover, MHR (p=0.019) value was significantly higher in Group 3 compared to Group 2. On the other hand other systemic inflammatory markers exhibited no significant difference between the groups (p>0.05).
Conclusion
The elevated MHR levels may indicate systemic inflammation in TED patients with abnormal thyroid function, and this may have an impact on the clinical course of TED. Even if other systemic inflammatory markers remain unchanged, the change in MHR levels is significant in this group of patients. Therefore, cautious control of thyroid hormone levels is crutial in the management of TED.
Additional Authors
| First name | Last name | Base Hospital / Institution |
|---|---|---|
| Nilay | Yüksel | Bilkent City Hospital |